NCT04881006View on ClinicalTrials.gov

Bioequivalence of Dapagliflozin 10 mg Tablets Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 10, 2020

Primary Completion Date

December 20, 2020

Study Completion Date

January 15, 2021

Conditions
Healthy Subjects
Interventions
DRUG

Dapagliflozin 10 mg tablets

Manufactured by Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

DRUG

Farxiga® 10 mg tablets

Manufactured by AstraZeneca Pharmaceuticals LP

Trial Locations (1)

Unknown

Pharma Medica Research Inc., Toronto

Sponsors
All Listed Sponsors
lead

Jiangsu Hansoh Pharmaceutical Co., Ltd.

INDUSTRY